Cargando…
Dexamethasone-Enhanced Continuous Online Microdialysis for Neuromonitoring of O(2) after Brain Injury
[Image: see text] Traumatic brain injury (TBI) is a major public health crisis in many regions of the world. Severe TBI may cause a primary brain lesion with a surrounding penumbra of tissue that is vulnerable to secondary injury. Secondary injury presents as progressive expansion of the lesion, pos...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360069/ https://www.ncbi.nlm.nih.gov/pubmed/37369003 http://dx.doi.org/10.1021/acschemneuro.2c00703 |
_version_ | 1785076020631568384 |
---|---|
author | Robbins, Elaine M. Jaquins-Gerstl, Andrea S. Okonkwo, David O. Boutelle, Martyn G. Michael, Adrian C. |
author_facet | Robbins, Elaine M. Jaquins-Gerstl, Andrea S. Okonkwo, David O. Boutelle, Martyn G. Michael, Adrian C. |
author_sort | Robbins, Elaine M. |
collection | PubMed |
description | [Image: see text] Traumatic brain injury (TBI) is a major public health crisis in many regions of the world. Severe TBI may cause a primary brain lesion with a surrounding penumbra of tissue that is vulnerable to secondary injury. Secondary injury presents as progressive expansion of the lesion, possibly leading to severe disability, a persistent vegetive state, or death. Real time neuromonitoring to detect and monitor secondary injury is urgently needed. Dexamethasone-enhanced continuous online microdialysis (Dex-enhanced coMD) is an emerging paradigm for chronic neuromonitoring after brain injury. The present study employed Dex-enhanced coMD to monitor brain K(+) and O(2) during manually induced spreading depolarization in the cortex of anesthetized rats and after controlled cortical impact, a widely used rodent model of TBI, in behaving rats. Consistent with prior reports on glucose, O(2) exhibited a variety of responses to spreading depolarization and a prolonged, essentially permanent decline in the days after controlled cortical impact. These findings confirm that Dex-enhanced coMD delivers valuable information regarding the impact of spreading depolarization and controlled cortical impact on O(2) levels in the rat cortex. |
format | Online Article Text |
id | pubmed-10360069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-103600692023-07-22 Dexamethasone-Enhanced Continuous Online Microdialysis for Neuromonitoring of O(2) after Brain Injury Robbins, Elaine M. Jaquins-Gerstl, Andrea S. Okonkwo, David O. Boutelle, Martyn G. Michael, Adrian C. ACS Chem Neurosci [Image: see text] Traumatic brain injury (TBI) is a major public health crisis in many regions of the world. Severe TBI may cause a primary brain lesion with a surrounding penumbra of tissue that is vulnerable to secondary injury. Secondary injury presents as progressive expansion of the lesion, possibly leading to severe disability, a persistent vegetive state, or death. Real time neuromonitoring to detect and monitor secondary injury is urgently needed. Dexamethasone-enhanced continuous online microdialysis (Dex-enhanced coMD) is an emerging paradigm for chronic neuromonitoring after brain injury. The present study employed Dex-enhanced coMD to monitor brain K(+) and O(2) during manually induced spreading depolarization in the cortex of anesthetized rats and after controlled cortical impact, a widely used rodent model of TBI, in behaving rats. Consistent with prior reports on glucose, O(2) exhibited a variety of responses to spreading depolarization and a prolonged, essentially permanent decline in the days after controlled cortical impact. These findings confirm that Dex-enhanced coMD delivers valuable information regarding the impact of spreading depolarization and controlled cortical impact on O(2) levels in the rat cortex. American Chemical Society 2023-06-27 /pmc/articles/PMC10360069/ /pubmed/37369003 http://dx.doi.org/10.1021/acschemneuro.2c00703 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Robbins, Elaine M. Jaquins-Gerstl, Andrea S. Okonkwo, David O. Boutelle, Martyn G. Michael, Adrian C. Dexamethasone-Enhanced Continuous Online Microdialysis for Neuromonitoring of O(2) after Brain Injury |
title | Dexamethasone-Enhanced
Continuous Online Microdialysis
for Neuromonitoring of O(2) after Brain Injury |
title_full | Dexamethasone-Enhanced
Continuous Online Microdialysis
for Neuromonitoring of O(2) after Brain Injury |
title_fullStr | Dexamethasone-Enhanced
Continuous Online Microdialysis
for Neuromonitoring of O(2) after Brain Injury |
title_full_unstemmed | Dexamethasone-Enhanced
Continuous Online Microdialysis
for Neuromonitoring of O(2) after Brain Injury |
title_short | Dexamethasone-Enhanced
Continuous Online Microdialysis
for Neuromonitoring of O(2) after Brain Injury |
title_sort | dexamethasone-enhanced
continuous online microdialysis
for neuromonitoring of o(2) after brain injury |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360069/ https://www.ncbi.nlm.nih.gov/pubmed/37369003 http://dx.doi.org/10.1021/acschemneuro.2c00703 |
work_keys_str_mv | AT robbinselainem dexamethasoneenhancedcontinuousonlinemicrodialysisforneuromonitoringofo2afterbraininjury AT jaquinsgerstlandreas dexamethasoneenhancedcontinuousonlinemicrodialysisforneuromonitoringofo2afterbraininjury AT okonkwodavido dexamethasoneenhancedcontinuousonlinemicrodialysisforneuromonitoringofo2afterbraininjury AT boutellemartyng dexamethasoneenhancedcontinuousonlinemicrodialysisforneuromonitoringofo2afterbraininjury AT michaeladrianc dexamethasoneenhancedcontinuousonlinemicrodialysisforneuromonitoringofo2afterbraininjury |